Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
To evaluate the effect of glutamine supplement on patients with burns, we conducted a systematic review and meta-analysis via synthesizing up-to-date studies. Databases including PubMed, Cochrane Central Register, EMBASE, and Google scholar, Wanfang data, and ClinicalTrials.gov were searched up to Oct, 2023 to find randomized trials evaluating glutamine supplement on patients with burns. Main outcomes included hospital stay, in hospital mortality, infection, and wound healing. Twenty-two trials which randomized a total of 2,170 patients were included in this meta-analysis. Pooled the length of hospital stay was shortened by glutamine supplement (WMD = -7.95, 95%CI -10.53 to -5.36, I2 = 67.9%, 16 trials)). Both pooled wound healing rates (WMD = 9.15, 95%CI 6.30 to 12.01, I2 = 82.7%, six studies) and wound healing times (WMD = -5.84, 95%CI -7.42 to -4.27, I2 = 45.7%, seven studies) were improved by glutamine supplement. Moreover, glutamine supplement reduced wound infection (RR = 0.38, 95%CI 0.21 to 0.69, I2 = 0%, three trials), but not non-wound infection (RR = 0.88, 95%CI 0.73 to 1.05, I2 = 39.6%, 9 trials). Neither in hospital mortality (RR = 0.95, 95%CI 0.74 to 1.22, I2 = 36.0%, eight trials) nor the length of ICU stay (WMD = 1.85, 95%CI -7.24 to 10.93, I2 = 78.2%, five studies) was improved by glutamine supplement. Subgroup analysis showed positive effects were either influenced by or based on small-scale, single center studies. Based on the current available data, we do not recommend routine use of glutamine supplement for burn patients in hospital. Future large-scale randomized trials are still needed to give a conclusion about the effect of glutamine supplement on burn patients.
To evaluate the effect of glutamine supplement on patients with burns, we conducted a systematic review and meta-analysis via synthesizing up-to-date studies. Databases including PubMed, Cochrane Central Register, EMBASE, and Google scholar, Wanfang data, and ClinicalTrials.gov were searched up to Oct, 2023 to find randomized trials evaluating glutamine supplement on patients with burns. Main outcomes included hospital stay, in hospital mortality, infection, and wound healing. Twenty-two trials which randomized a total of 2,170 patients were included in this meta-analysis. Pooled the length of hospital stay was shortened by glutamine supplement (WMD = -7.95, 95%CI -10.53 to -5.36, I2 = 67.9%, 16 trials)). Both pooled wound healing rates (WMD = 9.15, 95%CI 6.30 to 12.01, I2 = 82.7%, six studies) and wound healing times (WMD = -5.84, 95%CI -7.42 to -4.27, I2 = 45.7%, seven studies) were improved by glutamine supplement. Moreover, glutamine supplement reduced wound infection (RR = 0.38, 95%CI 0.21 to 0.69, I2 = 0%, three trials), but not non-wound infection (RR = 0.88, 95%CI 0.73 to 1.05, I2 = 39.6%, 9 trials). Neither in hospital mortality (RR = 0.95, 95%CI 0.74 to 1.22, I2 = 36.0%, eight trials) nor the length of ICU stay (WMD = 1.85, 95%CI -7.24 to 10.93, I2 = 78.2%, five studies) was improved by glutamine supplement. Subgroup analysis showed positive effects were either influenced by or based on small-scale, single center studies. Based on the current available data, we do not recommend routine use of glutamine supplement for burn patients in hospital. Future large-scale randomized trials are still needed to give a conclusion about the effect of glutamine supplement on burn patients.
Nutritional therapy is very important in burn patients and plays a role in the prevention and treatment of malnutrition. Therefore, it is necessary to assess nutritional status, prevent or minimize nutritional problems, and monitor nutritional therapy. This study was conducted to determine the nutritional risk, nutritional status and biochemical parameters of adult burn patients in the burn intensive care unit. The 59 patients (women: 16, men: 43) between the ages of 19-64 were included in the study. Parameters such as NRS-2002 (admission and discharge), dietary intake, nutritional support status, serum albumin, and total protein (admission and discharge) were evaluated to determine the nutritional risk and nutritional status of the patients. In addition, body weight, mid-upper arm circumference, and triceps skinfold thickness were measured and body mass index was calculated (admission and discharge). The duration of hospitalization and burn percentage of men patients were higher than women (P < 0.05). A significant decreases were determined in the mean body weight, body mass index, and triceps skinfold thickness of men patients at discharge compared to admission (P < 0.05). In men patients, a statistically significant difference was found in serum albumin, hemoglobin, and hematocrit values between admission and discharge (P < 0.05). A statistically significant difference was found in NRS-2002 scores at admission and discharge in both genders, and the scores increased (P < 0.05). While a significant relationship was found between immunonutrition support and gender (P < 0.05), no relationship was found between genders in terms of the diet given and the consumption status of the diet intake (P > 0.05). No statistically significant difference was found between genders in terms of feeding duration with nutritional support products, energy intake with nutritional support products and diet, macronutrients, and total energy expenditure values (P > 0.05). Since burn injuries can cause serious metabolic disorders, impaired nutritional status was encountered during hospitalization. While the treatment process was positively affected by the increase in the NRS-2002 score during hospitalization, a decrease in parameters such as albumin, total protein, and anthropometric measurement values brought about by the catabolic process was encountered. Therefore, to prevent or treat malnutrition, the nutritional status of patients should be evaluated at the time of hospitalization and they should be able to receive the necessary nutritional support.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.